Opinions & Features

All day Monday, on TV and Twitter you could hear investors, Big Pharma, biotech executives and politicians all saying the same thing: “What’s next?”

Over 2,500 years ago, Thucydides, known as the father of scientific history because he relied on facts and his observations rather than divine intervention to explain events, once described a plague that struck Athens. As[...]

Just when you think a biotech bear market is about to descend, the bulls come rushing in.

Word of Beau Biden, Jr.’s death stunned the nation. It was a sudden loss, unexpected news that chimed and buzzed over smartphones everywhere and then flashed over television screens across the country.

Steve Brozak sees a bubble getting larger, and he is anticipating the time when biotech stocks pull back to take a breather, like all high-flying markets ultimately do.

There are very few assurances in life, but in the field of generic pharmaceuticals, there are three certainties we are about to witness

At a little after 12:00 AM Pacific Time consumers will be able to pre-order the Apple Watch online for delivery on April 24th.

Rather than focusing on the noble quest of a few scientists and physicians, we must face the reality that cancer is a business.

A deadly strain of antibiotic-resistant bacteria, dubbed “nightmare bacteria” by the head of the Centers for Disease Control and Prevention (CDC), has struck again.

When President Obama unveiled his Precision Medicine Initiative, he declared a two-fold challenge.